The Big Pharma unveiled the first winners of the ... The award program's logo. (AbbVie) To enter the contest, individuals were asked to submit a written essay or recorded video or audio clip ...

A sign with the company logo sits on the headquarters ... guidance thanks to a surge in demand for the pharma giant’s COVID-19 medications. AbbVie (ABBV) announced Monday that it is buying ...

Abivax Announces Former Prometheus COO, Mark Stenhouse, Appointed as Board Observer & Advisor to Abivax ...

Continuity Biosciences, LLC, a new bioscience company dedicated to developing and commercializing cutting-edge technologies for cell ...

On 14 November, Eli Lilly became a part of this group, after an account using its name and logo ... pharma companies, HCPs, and patients that rely on the platform for communication. Pharma giant ...

Most pharmaceutical businesses are slow-moving by nature due to the lengthy amount of time it takes to develop a new medicine ...

AbbVie (ABBV) shares snapped eight consecutive sessions of losses as the stock closed up XYZ% at $XYZ. The North ...

In a report released yesterday, Charlie CY Yang from Bank of America Securities reiterated a Buy rating on Royalty Pharma (RPRX – Research ...

The shocking failure of AbbVie’s emraclidine has investors questioning the Big Pharma’s long-term neuroscience strategy, ...

In a report released today, Mohit Bansal from Wells Fargo maintained a Buy rating on AbbVie (ABBV – Research Report), with a price target of $195.00. The company’s shares closed last Friday at $164.99 ...

On Friday, AbbVie Inc (ABBV) stock saw a decline, ending the day at $164.99 which represents a decrease of $-4.64 or -2.74% from the prior close of $169.63. The stock opened at $169.63 and touched a ...

AbbVie is reaching for the Sky(rizi ... the latest figures by real-time ad trackers iSpot.TV, which sees the Big Pharma dig deep into its wallet as it handed over nearly $19 million more for ...